Vocodia Holdings Corp Delivers a Corporate Update on Strategic Growth
17 avr. 2024 08h00 HE
|
Vocodia Holdings Corp.
Vocodia Holdings Corp Delivers a Corporate Update on Strategic Growth
Auto Parts 4 Less Group Inc. Reports Substantial Revenue Growth and Continued Financial Progress
17 avr. 2024 08h00 HE
|
Auto Parts 4Less Group Inc
Auto Parts 4 Less Group Inc. Reports Substantial Revenue Growth and Continued Financial Progress
BranchOut Food Strengthens Financial Position with Successful Sale of Senior Secured Promissory Notes and Warrants
17 avr. 2024 08h00 HE
|
BranchOut Food Inc.
BranchOut Food Strengthens Financial Position with Successful Sale of Senior Secured Promissory Notes and Warrants
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
17 avr. 2024 08h00 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update
16 avr. 2024 09h15 HE
|
Rodedawg International Industries, Inc.
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update
Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution
16 avr. 2024 08h00 HE
|
Avant Technologies, Inc.
Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution
Dr. Michael Leonard Joins Ingredion as Senior Vice President, Chief Innovation Officer and Head of Protein Fortification
15 avr. 2024 14h00 HE
|
Ingredion Incorporated
WESTCHESTER, Ill., April 15, 2024 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced the...
American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
12 avr. 2024 18h39 HE
|
American Shared Hospital Services
American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
Oncocyte Reports Full Year 2023 Financial Results
12 avr. 2024 06h00 HE
|
OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
11 avr. 2024 21h46 HE
|
OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules